ArticleJournal of computer-aided molecular design2025
3d electron cloud descriptors for enhanced QSAR modeling of anti-colorectal cancer compounds.
Article in Journal of computer-aided molecular design, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
To address limitations of conventional Quantitative Structure-Activity Relationship (QSAR) descriptors in capturing molecular electronic and spatial complexity, we developed a high-dimensional framework using three-dimensional electron density features. Electron densities were computed via density functional theory (DFT), converted to 3D point clouds, and encoded into multi-scale descriptors including radial distribution functions, spherical harmonic expansions, point feature histograms, and persistent homology. This design enabled molecular characterization across statistical, geometric, and topological dimensions. The proposed descriptors consistently improved performance across multiple machine learning models; for instance, Area Under the Curve (AUC) increased from 0.88 to 0.96 with Light Gradient Boosting Machine (LightGBM). Benchmarking demonstrated superior performance versus industry-standard ECFP4 fingerprints. Control experiments using purely geometric (CPK) point clouds yielded substantially lower performance, confirming that predictive gains stem from electronic structure information rather than high-dimensional geometry alone. Feature attribution analysis revealed that local geometric descriptors and intensity-based electronic features were primary contributors, while integration with conventional 1D/2D descriptors further enhanced accuracy, indicating strong complementarity. Model robustness was validated through DeLong and permutation tests, calibration assessments, and applicability domain analysis. This study provides proof-of-concept evidence that DFT-derived electron density features can be systematically integrated into QSAR modeling. Despite computational cost limitations and reduced chemical interpretability, results demonstrate that electronic-structure-based descriptors offer valuable complementarity to established approaches, opening new avenues for molecular representation in drug discovery.
Indexed as
Identifiers
41136856What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.